Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391898
Status:
COMPLETED
Last Update Posted:
2011-03-15
First Post:
2006-10-24
Brief Title:
Efficacy of LevodopaCarbidopaEntacapone vs LevodopaCarbidopa in Parkinsons Disease Patients With Early Wearing-off
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 3-month Multi-center Double-blind Randomized Study to Evaluate the Efficacy of LevodopaCarbidopaEntacapone vs LevodopaCarbidopa in Parkinsons Disease Patients With Impairment of Activities of Daily Living and Early Wearing-off With Levodopa
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study evaluated the efficacy of levodopacarbidopaentacapone vs levodopacarbidopa in patients with Parkinsons disease and early wearing-off with levodopa
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None